BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37468236)

  • 1. Clinical phenotype and genetic function analysis of a rare family with hereditary leiomyomatosis and renal cell carcinoma complicated with Birt-Hogg-Dubé syndrome.
    Pan HH; Ruan DD; Wu M; Chen T; Lu T; Gan YM; Wang C; Liao LS; Lin XF; Chen X; Zhu YB; Fang ZT; Yu QH; Yang GK; Ye LF; Luo JW
    J Med Genet; 2023 Nov; 60(12):1210-1214. PubMed ID: 37468236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
    Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
    Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birt-Hogg-Dubé syndrome with clear cell renal cell carcinoma in a Chinese family.
    Lin Z; Gong K; Pang B; Zeng C; Zhang D
    Intern Med; 2014; 53(24):2825-8. PubMed ID: 25500447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
    Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
    Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata.
    Shi Y; Xu Y; Wang C; Chen Y; Ren X; Kang Y; Wang C
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
    Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
    Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.
    Bandini E; Zampiga V; Cangini I; Ravegnani M; Arcangeli V; Rossi T; Mammi I; Schiavi F; Zovato S; Falcini F; Calistri D; Danesi R
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
    Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
    Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population.
    Savatt JM; Shimelis H; Moreno-De-Luca A; Strande NT; Oetjens MT; Ledbetter DH; Martin CL; Myers SM; Finucane BM
    Genet Med; 2022 Sep; 24(9):1857-1866. PubMed ID: 35639097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel heterozygous mutation in the Birt-Hogg-Dubé Syndrome.
    Gómez Rivas J; Carrión DM; Alonso Y Gregorio S; Álvarez-Maestro M; Tabernero Gómez Á; Cisneros Ledo J
    Arch Esp Urol; 2017 Sep; 70(7):675-678. PubMed ID: 28891800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary kidney cancer: unique opportunity for disease-based therapy.
    Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
    Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome.
    Sánchez-Heras AB; Dámaso E; Castillejo A; Robledo M; Teulé A; Lázaro C; Sánchez-Martínez R; Zúñiga Á; López-Fernández A; Balmaña J; Robles L; Ramon Y Cajal T; Castillejo MI; Ibañez RP; Sevila CM; Sánchez-Mira A; Escandell I; Gómez L; Berbel P; Soto JL
    Orphanet J Rare Dis; 2024 Jan; 19(1):26. PubMed ID: 38279137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
    Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
    Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
    Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.